Atara Biotherapeutics Inc. (ATRA)
| Sector: | Health Care |
| Super Investor Stats: | |
| Ownership count: | 0 |
| Ownership rank: | -- |
| % of all portfolios: | 0% |
| History | Portfolio Manager | Activity ▲ | Share change | % change to portfolio | |
| Q4 2023 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Sell 100.00% | 251,629 | 0.22 | |
| ≡ | Seth Klarman - Baupost Group | Sell 100.00% | 390,945 | 0.28 | |
| Q1 2023 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Reduce 0.00% | 12 | 0.00 | |
| Q4 2022 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Reduce 19.92% | 62,593 | 0.12 | |
| Q1 2022 | |||||
| ≡ | Seth Klarman - Baupost Group | Reduce 4.17% | 14,155 | 0.04 | |
| Q1 2021 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Reduce 7.99% | 23,406 | 0.08 | |
| ≡ | Seth Klarman - Baupost Group | Reduce 6.93% | 25,260 | 0.07 | |
| Q4 2020 | |||||
| ≡ | Seth Klarman - Baupost Group | Reduce 8.19% | 32,522 | 0.15 | |
| Q3 2020 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Reduce 0.12% | 313 | 0.00 | |
| Q4 2019 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Reduce 2.85% | 5,822 | 0.03 | |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.